Sensory Evaluation of the Taste of Pediatric Medicines
NCT03627351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 154
Last updated 2024-03-04
Summary
The investigators will conduct a systematic study of the sensory perception of a diverse set of commonly used pediatric liquid medications and excipients in tandem with an equally complete genetic analysis of the adult sensory panelists to investigate the relationship between genetic variation and individual differences in the perceived flavor (taste, smell, irritation) of pediatric medicines. The flavor of each medicine and excipient will be measured individually using both cognitively demanding methods unsuitable for young children and simpler measures validated for use by children. Salivary DNA samples will be collected to carry out genome wide association study (GWAS).
Conditions
- Healthy
Sponsors & Collaborators
-
National Institute on Deafness and Other Communication Disorders (NIDCD)
collaborator NIH -
Children's Hospital of Philadelphia
collaborator OTHER -
Monell Chemical Senses Center
lead OTHER
Principal Investigators
-
Julie A. Mennella, PhD · Monell Chemical Senses Center
-
Elizabeth Lowenthal, MD · Children's Hospital of Philadelphia
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2021-07-16
- Completion
- 2024-03-01
Countries
- United States
Study Locations
More Related Trials
-
Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children
NCT01082029 ·Status: COMPLETED ·Phase: PHASE4
-
Spectroscopic Evaluation of Middle Ear Infection
NCT04812093 ·Status: RECRUITING
-
Prevention of Noise-induced Hearing Loss
NCT02049073 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Expanded Indications in the MED-EL Pediatric Cochlear Implant Population
NCT03900897 ·Status: COMPLETED ·Phase: NA
-
Vaccination for Middle Ear Infection
NCT00001605 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media
NCT03766373 ·Status: COMPLETED ·Phase: PHASE1
-
Coherent Optical Detection of Middle Ear Disease
NCT05353569 ·Status: RECRUITING ·Phase: NA
-
Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease
NCT00802529 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media
NCT02567825 ·Status: COMPLETED ·Phase: NA
-
Autoimmunity in Inner Ear Disease
NCT00000361 ·Status: TERMINATED ·Phase: PHASE3
-
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
NCT05730283 ·Status: RECRUITING ·Phase: PHASE2
-
AM-111 in the Treatment of Acute Inner Ear Hearing Loss
NCT02561091 ·Status: COMPLETED ·Phase: PHASE3
-
Homeopathic Ear Drops for Otitis Media Study
NCT01003210 ·Status: COMPLETED ·Phase: NA
-
Observation of Gas Exchange in the Middle Ear
NCT00794105 ·Status: UNKNOWN
-
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
NCT01588535 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of SENS 401 in Healthy Subjects
NCT03071003 ·Status: COMPLETED ·Phase: PHASE1
-
Do We Need to Taper Down Steroid Therapy for Bell's Palsy
NCT04406376 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes
NCT04218123 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Evaluate SPI-1005 in Adults With Meniere's Disease
NCT02603081 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss
NCT00802425 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Simethicone on Eustachian Tube Dysfunction
NCT01312038 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants
NCT06208540 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of Nasal Steroids in Treatment of Otitis Media With Effusion: Acomparative Study
NCT03491098 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
NCT02038972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
AM-101 in the Treatment of Acute Tinnitus 3
NCT02040194 ·Status: COMPLETED ·Phase: PHASE3